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Outcomes of ureteroscopy 
miniaturization on tissue damage 
and tissue hypoxia in a pig model
Juan P. Caballero-Romeu  1, Juan A. Galán-Llopis2, Federico Soria3, Esther Morcillo-Martín3, 
Pablo Caballero-Pérez4, Julia E. De La Cruz-Conty3 & Jesús Romero-Maroto5
Miniaturization of ureteroscopy materials is intended to decrease tissue damage. However, tissue 
hypoxia and the gross and microscopic effects on tissue have not been adequately assessed. We 
compared the gross and microscopic effects of micro-ureteroscopy (m-URS) and conventional 
ureteroscopy (URS) on the urinary tract. We employed 14 pigs of the Large White race. URS was 
performed in one of the ureters with an 8/9.8 F ureteroscope, while a 4.85 F m-URS sheath was used 
in the contralateral ureter. Gross assessment of ureteral wall damage and ureteral orifice damage 
was performed. For microscopic assessment hematoxylin-eosin staining and immunohistochemistry 
for detection of tissue hypoxia were conducted. Regarding the macroscopic assessment of ureteral 
damage, substantial and significant differences were recorded using URS (C = 0.8), but not with 
m-URS. Microscopic assessment after staining with hematoxylin-eosin revealed greater epithelial 
desquamation in the URS group (p < 0.05). Pimonidazole staining revealed greater hypoxia in the 
epithelial cells than in the remainder of the ureteral layers. We conclude that m-URS causes less damage 
to the ureteral orifice than URS. Histopathological findings show m-URS reduces ureteral epithelial 
damage compared with conventional ureteroscopy. Both URS and m-URS cause cellular hypoxia.
As a result of technological advances in ureteroscopes, imaging systems and ancillary devices, ureteroscopy has 
become one of the fundamental techniques used in endourology1. The new ureteroscopes allow us to main-
tain good operating conditions, with good irrigation flow, good visibility and the capacity to introduce ancillary 
instruments, using instruments of increasingly smaller calibers. Miniaturization should preserve the efficacy of 
the technique while reducing the complications derived from tissue damage caused by the ureteroscope within 
the urinary tract.
Damage to the ureteral wall has been associated with complications such as hematuria, postoperative edema 
or renoureteral colic. Vesicoureteral reflux, in turn, has been associated with loss of the valve mechanism of the 
orifice and intramural ureter. Furthermore, some authors have related the degree of ureteral damage to the need 
for postoperative ureteral stent placement and its duration2. On the other hand, ureteral stricture may also have 
an inflammatory and/or ischemic component3.
To further reduce ureteroscope caliber, micro-ureteroscopy (m-URS) was first described in 2014 as a ureter-
oscope using a 4.85 F (French) sheath of the micropercutaneous surgery set for the treatment of distal ureteral 
lithiasis in women, with satisfactory results4,5. Recently, Utanğaç et al. performed m-URS in a series of 11 children 
with a mean age of 55.1 months6. The authors reported that ureteral access in the pediatric patients could be car-
ried out in all cases without preoperative ureteral stenting or dilatation of the ureteral orifice.
No comparative studies reporting scientific evidence at the micro- or macroscopic level of the ureteral effects 
of ureteroscopes of different calibers have been published. Therefore, the purpose of this experimental study 
was to determine whether micro-ureteroscopy performed with the 4.85 F access sheath of the micro-Perc® set 
(Polydiagnost, Germany) produces fewer adverse effects compared with a conventional 8/9.8 F ureteroscope, 
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defined as less macroscopic damage to the ureteral wall, less macroscopic damage to the ureteral orifice (UO), less 
microscopic damage to the ureteral wall, and less tissue ischemia.
Results
Macroscopic assessment. In the blinded macroscopic assessment of ureteral damage, 84.62% of the ure-
teral orifices in which m-URS (Fig. 1) was performed showed no changes at the end of the procedure versus 
15.38% in the URS group (p < 0.01) (Table 1). No differences between the baseline and final conditions of the 
ureteral orifice (UO) were observed with m-URS (C = 0.2). In contrast, substantial and significant differences 
were recorded using URS (p < 0.01), with an effect size of 0.8 (95% confidence interval [CI] 0.5-1) (Fig. 2). After 
m-URS, we identified 2 lesions of grade 1, while after URS, 9 lesions of grade 1 and 2 lesions of grade 2 were regis-
tered. The lesions, as scored by the Post-Ureteroscopic Lesion Scale (PULS), were greater in the URS group, with 
one grade 3 lesion (7.7%) versus one grade 1 lesion in the m-URS group (7.7%), though the differences between 
the two groups failed to reach statistical significance.
Microscopic ureteral damage assessment. Staining with hematoxylin-eosin (Table 2) revealed diffuse 
epithelial desquamation in 35.7% of the ureters in the URS group versus in 14.3% of the ureters in the m-URS 
group (p < 0.05). The effect of URS was substantial and significant, with C = 0.8 (0.5–0.9), while m-URS pro-
duced little and nonsignificant desquamation (Fig. 3). Ureteral edema, infiltration, fibrosis and congestion were 
identified in both groups in the proximal and distal ureter (Fig. 4). The differences in these measures between 
the two groups were not statistically significant. Ureteral bleeding was only identified focally in the URS group in 
Figure 1. A longitudinal view of the m-URS ureteroscope and 4.85 F sheath is shown at the top. The tips of both 
instruments are shown at the bottom.
Scale n (%)
L
Effect size
0 1 2 3 Wil.+ C 95% CI
Ureteral Orifice
Score Baseline URS 13 (100) 0 0 0 1 66.0** 0.8 (0.5; 1.0)
m-URS 13 (100) 0 0 0 2 3.0 0.2 (0.0; 0.3)
End URS 2 (15.4) 9 (69.2) 2 (15.4) 0 5 0.0** −0.7 (−0.9; −0.4)
m-URS 11 (84.6) 2 (15.4) 6 0.0** −0.7 (−0.9; −0.4)
Ureter integrity
PULS Baseline URS 13 (100) 0 0 0 1 3.0 0.2 (0.0; 0.3)
m-URS 13 (100) 0 0 0 2 1.0 0.1 (−0.1; 0.2)
30 min URS 12 (92.3) 0 0 1 (7.7) 3 1.0 0.1 (−0.1; 0.2)
m-URS 12 (92.3) 1 (7.7) 0 0 4 1.0 0.1 (−0.1; 0.2)
End URS 12 (92.3) 1 (7.7) 0 1 (7.7) 5 1.5 0.1 (−0.2; 0.3)
m-URS 12 (92.3) 1 (7.7) 0 0 6 1.5 0.1 (−0.2; 0.3)
Table 1. Macroscopic evaluation of tissue damage. Wil.+: Wilcoxon positive range statistic. C. Cliff ’s delta. 
95% CI: 95% confidence interval for Cliff ’s delta. L: Legend, comparison between 1; Final URS vs Baseline 
URS, 2; Final m-URS vs Baseline mURS,3; 30 minutes URS vs Baseline URS,4; 30 minutes m-URS vs Baseline 
m-URS, 5; Final URS vs Final m-URS, 6; Final URS-Baseline URS vs Final m-URS – Baseline m-URS *p < 0.05, 
**p < 0.01.
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Figure 2. Comparison of the condition of the ureteral orifices after ureteral exploration. The ureteral orifice of a 
ureter explored with m-URS is shown at left. The ureteral orifice of a ureter explored with URS is shown at right.
Absent Focal Diffuse Severe
L Wil.+
Effect size
n (%) n (%) n (%) n (%) C 95% CI
EPITHELIUM
Ureteral desquamation
Prox. u.
URS 3 (21.4) 11 (78.6) 0 0 1 55** 0.8 (0.5; 0.9)
m-URS 3 (21.4) 11 (78.6) 0 0 2 24.5 0.3 (0.0; 0.6)
Distal u.
URS 0 4 (28.6) 5 (35.7) 5 (35.7) 3 0** −0.5 (−0.8; −0.1)
m-URS 1 (7.1) 10 (71.4) 2 (14.3) 1 (7.1) 4 0** −0.5 (−0.8; −0.1)
LAMINA PROPRIA
Ureteral edema
Prox. u.
URS 4 (28.6) 8 (57.1) 2 (14.3) 0 1 45.5 0.2 (−0.2; 0.6)
m-URS 3 (21.4) 8 (57.1) 3 (21.4) 0 2 27.5 0.0 (−0.4; 0.4)
Distal u.
URS 4 (28.6) 4 (28.6) 5 (35.7) 1 (7.1) 3 16.5 −0.1 (−0.5; 0.3)
m-URS 3 (21.4) 8 (57.1) 3 (21.4) 0 4 16.5 −0.2 (−0.6; 0.2)
Ureteral infiltration
Prox. u.
URS 5 (35.7) 6 (42.9) 3 (21.4) 1 7 −0.1 (−0.5; 0.3)
m-URS 7 (50.0) 6 (42.9) 1 (7.1) 2 7 −0.1 (−0.5; 0.3)
Distal u.
URS 4 (28.6) 10 (71.4) 0 3 3.5 −0.3 (−0.6; 0.1)
m-URS 8 (57.1) 6 (42.9) 0 4 3.5 0.0 (0.4; −0.4)
Ureteral fibrosis
Prox. u.
URS 10 (71.4) 1 (7.1) 3 (21.4) 1 40.5 0.2 (−0.2; 0.6)
m-URS 8 (57.1) 6 (42.9) 0 2 28 0.3 (−0.1; 0.6)
Distal u.
URS 5 (35.7) 8 (57.1) 1 (7.1) 3 30 0.0 (−0.3; 0.4)
m-URS 5 (35.7) 7 (50.0) 2 (14.3) 4 30 0.0 (0.4; −0.4)
Ureteral congestion
Prox. u.
URS 11 (78.6) 3 (21.4) 0 1 6 0.2 (−0.2; 0.5)
m-URS 12 (85.7) 2 (14.3) 0 2 1.5 0.0 (−0.3; 0.3)
Distal u.
URS 9 (64.3) 4 (28.6) 1 (7.1) 3 3.5 −0.2 (−0.5; 0.1)
m-URS 12 (85.7) 2 (14.3) 0 4 3.5 −0.2 (−0.5; 0.1)
Ureteral bleeding
Prox. u.
URS 14 (100) 0 1 3 0.1 (−0.1; 0.3)
m-URS 14 (100) 0 2 0 0.0 (0.0; 0.0)
Distal u.
URS 12 (85.7) 2(14.3) 3 0 −0.1 (−0.3; 0.1)
m-URS 14 (100) 0 4 0 −0.1 (−0.3; 0.1)
MUSCLE LAYER
Fibrosis
Prox. u.
URS 12 (85.7) 2 (14.3) 1 7.5 0.1 (−0.2; 0.4)
m-URS 11 (78.6) 3 (21.4) 2 9 0.1 (−0.3; 0.4)
Distal u.
URS 10 (71.4) 4 (28.6) 3 10.5 0.0 (−0.3; 0.3)
m-URS 10 (71.4) 4 (28.6) 4 10.5 −0.1 (−0.4; 0.3)
Table 2. Histopathological evaluation (hematoxylin-eosin staining). Wil.+: Wilcoxon positive range statistic. 
C. Cliff ’s delta. 95% CI: 95% confidence interval for Cliff ’s delta. L: Legend, comparison between 1; Distal u. 
URS vs Prox. u. URS, 2; Distal u. m-URS vs Prox. u. m-URS, 3; Distal u. URS vs Distal u. m-URS, 4; Distal u. 
URS - Prox. u. Baseline URS vs Distal u. m-URS – Prox. u. m-URS, *p < 0.05, **p < 0.01.
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two cases (14.3%). The presence of fibrosis in the muscle layer was focal in the proximal and distal ureter in both 
groups.
Comparison of the number of cases of damage to the lamina propria caused by URS and m-URS (Table 3) 
showed no significant changes in damage with either method, though admittedly four or more types of different 
lesions were identified only after URS in 4 cases (28.5%).
Hypoxia assessment. Pimonidazole staining (Table 4) revealed greater hypoxia in the nucleus and cyto-
plasm of the epithelial cells than in the remainder of the ureteral layers (Fig. 5). However, epithelial alteration in 
the proximal and distal ureteral zones was very similar with both URS and m-URS. Hypoxia affected 85.7% of 
nuclei in both groups in the proximal ureter. In the distal ureter, hypoxia was absent in 18.2% of cases in the URS 
group and 7.1% of cases in the m-URS group (NS) (Fig. 5). Pimonidazole staining was present in the cytoplasm in 
64.3% of cases in the proximal ureter of the URS group and 57.2% in the m-URS group (NS). In the distal ureter, 
hypoxia was absent in 54.4% of cases in the URS group and in 28.6% in the m-URS group. The two techniques 
likewise showed no statistically significant differences in the lamina propria or the muscle or serosal layer between 
the proximal and distal ureteral segments (Fig. 6).
Discussion
Ureteroscopy is a minimally invasive surgical technique. Although routine postoperative stenting is no longer 
recommended, a multicenter study demonstrated that, after 4475 ureteroscopies performed to treat distal ure-
teral stones, a double J stent was placed in 54.7% of patients7. Double J stents significantly reduce the quality of 
life of patients8. Micro-ureteroscopy was developed to reduce UO dilation and ureteral wall damage and, thus, to 
diminish postoperative stenting.
This study revealed that ureteral orifices in the m-URS group showed less damage. Damage to the UO is a key 
factor in the development of renoureteral colic episodes in the immediate postoperative period of ureteroscopy. 
The mucosal inflammatory reaction can significantly reduce the diameter of the distal ureter and cause flank 
pain9–11. Matani et al. found that 11.9% of 319 patients subjected to uncomplicated ureteroscopy required emer-
gency placement of a stent less than 24 hours after the procedure12. The authors identified ureteral edema as one of 
Figure 3. Ureter. (A) Intact epithelium (Lesion grade 0). (B) Loss of epithelium affecting less than half of 
the mucosa; focal loss (Lesion grade 1). (C) Intact epithelium of the ureter; lamina propria showing fibrosis 
extending towards the muscle layer (arrows). (D) In total, denuded mucosa; total loss of epithelium (Lesion 
grade 3). *Indicates moderate connective tissue edema of the lamina propria.
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the causes of the obstruction. The use of m-URS, therefore, could help avoid unnecessary ureteral stent placement 
in the absence of other risk factors for the development of post-ureteroscopy renoureteral colic episodes.
Furthermore, m-URS is the same caliber in its entire length unlike conventional ureteroscopes. Utanğaç et 
al. considered this finding to be relevant, even in comparison with 4.5/6.5 F ureteroscopes in pediatric patients, 
where the difference from m-URS was 25% at 5 cm from the tip of the instrument5. The decrease in instrument 
caliber from URS to m-URS was 39% at the tip of the instrument and 51% in the more proximal portion. m-URS 
might avoid the UO occlusion, and hence reduce renal intrapelvic pressure levels.
According to the authors of the PULS, grades 1 and 2 should be regarded as inherent to ureteroscopy and 
may imply the placement of a ureteral stent for some days, without being able to specify the exact duration 
of stenting2,13. The present study shows that m-URS offers advantages over URS in reducing ureteral epithelial 
desquamation. However, this difference was not noted by the participating surgeons. Epithelial desquamation as 
evidenced by the histopathology might not be assessable with the PULS or might not be clinically significant. In 
any case, the lesser epithelial damage observed in the hematoxylin-eosin staining could imply a decrease in the 
use of postoperative ureteral stents - with the consequent reduction of morbidity, improvement of patient quality 
of life7 and lowered costs associated with the endourological treatment of lithiasis.
Regarding the hypoxia assessment, one of the postulated causes of ureteral stricture is ischemia secondary to 
compression of the endoscopic material upon the ureteral wall. Lallas et al. used Doppler ultrasound to measure 
ureteral blood flow in a porcine model14. The authors compared three groups involving different caliber ureteral 
access sheaths (from 10–12 F to 14–16 F). No significant decrease in arterial flow could be demonstrated between 
the three groups. However, our study shows that oxygen supply at the cellular level is at least temporarily insuf-
ficient. A surprising finding was that a greater prevalence of epithelial cell nuclei with oxygen saturation levels 
<10 mmHg was noted in the proximal ureter not in contact with the ureteroscope than in the sections that came 
into contact with URS or m-URS. This only occurred at the epithelial level. In this regard, although transient and 
limited to the epithelium, ischemia caused by the intraluminal hydrostatic pressure might be more significant 
than the pressure exerted by the instruments. Further studies will be needed to determine the roles of other fac-
tors related to tissue hypoxia.
Some limitations of the study are to be acknowledged: firstly, the statistical power of the study might be insuf-
ficient to detect certain differences between the two techniques. On the other hand, we feel that the PULS may 
be useful in deciding whether to place a postoperative ureteral stent. However, this scale does not distinguish 
between lesions already present before treatment for lithiasis and lesions observed at the end of the procedure. 
Moreover, the study does not contemplate stone fragmentation, which reduces the likeliness of ureteral wall dam-
age, or the damage caused by renal lithiasis itself. Lastly, our study does not allow us to determine the mechanism 
underlying cellular ischemia at the proximal ureter with either URS or m-URS.
In summary, our study shows that m-URS causes less damage to the ureteral orifice than conventional 
ureteroscopy. The damage caused at the ureteral level is not noticeable when assessed using the PULS. The 
Figure 4. Ureter. (A) Loss of epithelium affecting less than half of the mucosa; focal loss (Lesion grade 1). The 
arrow indicates diffuse inflammatory infiltrate (B and C) Focal inflammatory infiltrates in the lamina propria.
Number of cases of damage
L Wil.+
Effect size0 1 2 3 4 5
n (%) n (%) n (%) n (%) n (%) n (%) C 95% CI
Prox. u.
URS 0 6 (42.9) 4 (28.6) 4 (28.6) 0 0 1 38.0 0.3 (−0.1; 0.7)
m-URS 1 (7.1) 5 (35.7) 3 (21.4) 5 (35.7) 0 0 2 32.5 0.1 (−0.3; 0.5)
Distal u.
URS 0 2 (14.3) 7 (50.0) 1 (7.1) 3 (21.4) 1 (7.1) 3 22.5 0.1 (−0.3; 0.5)
m-URS 1 (7.1) 3 (21.4) 5 (35.7) 5 (35.7) 0 0 4 37.0 −0.2 (−0.6; 0.2)
Table 3. Evaluation of lamina propria damage according to procedure. Wil.+: Wilcoxon positive range statistic. 
C. Cliff ’s delta. 95% CI: 95% confidence interval for Cliff ’s delta. L: Legend, comparison between 1; Distal ureter 
URS vs Proximal ureter URS, 2; Distal ureter m-URS vs Proximal ureter m-URS, 3; Distal ureter URS vs Distal 
ureter m-URS, 4; Distal ureter URS - Proximal ureter. Baseline URS vs Distal ureter m-URS – Distal ureter. 
m-URS, *p < 0.05, **p < 0.01.
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histopathological findings show m-URS reduces ureteral epithelial damage compared with conventional ureter-
oscopy. Both URS and m-URS cause cellular hypoxia, though this phenomenon cannot be exclusively attributed 
to endoscope contact with the ureteral wall.
Methods
A porcine model involving 14 healthy female pigs (Large White race) weighing 30–35 kg was used in this exper-
imental study. Three phases were established, as shown in the flow diagram (Fig. 6). The Institutional Ethics 
Committee for Animal Research of Jesús Usón Minimally Invasive Surgery Center approved the experimental 
protocol. The principles of laboratory animal care (NIH publication no. 86–23, revised 1985) were followed, as 
was the current version of the European Union Laws on the protection of animals used for scientific purposes.
Phase I: Animal model preparation. The animals were subjected to inhaled general anesthesia. To rule out 
abnormalities that could interfere with the results of the study, baseline evaluation was carried out in all animals. 
Absent
Present in 
few
Present in 
most
L Wil.+
Effect 
size
95% CIn (%) n (%) n (%) C
EPITHELIUM
Nucleus
Prox. u. URS 2 (14.3) 5 (35.7) 7 (50.0) 1 0 −0.1 (−0.5; 0.3)
m-URS 2 (14.3) 6 (42.9) 6 (42.9) 2 25 0.0 (−0.4; 0.4)
Distal u. URS 2 (18.2) 5 (45.5) 4 (36.4) 3 3 0.1 (−0.3; 0.5)
m-URS 1 (7.1) 7 (50.0) 6 (42.9) 4 6 0.2 (−0.2; 0.6)
Cytoplasm
Prox. u. URS 5 (35.7) 3 (21.4) 6 (42.9) 1 0* −0.2 (−0.5; 0.2)
m-URS 6 (42.9) 4 (28.6) 4 (28.6) 2 12 0.1 (−0.4; 0.5)
Distal u. URS 6 (54.5) 2 (18.2) 3 (27.3) 3 10* 0.2 (−0.2; 0.5)
m-URS 4 (28.6) 7 (50.0) 3 (21.4) 4 10* 0.4 (0.0; 0.7)
LAMINA PROPRIA
Cells
Prox. u. URS 9 (64.3) 5 (35.7) 0 1 12 0.2 (−0.2; 0.5)
m-URS 7 (50.0) 7 (50.0) 0 2 18 0.0 (−0.4; 0.3)
Distal u. URS 7 (50.0) 6 (42.9) 1 (7.1) 3 6 −0.1 (−0.4; 0.3)
m-URS 8 (57.1) 5 (35.7) 1 (7.1) 4 3 −0.2 (−0.5; 0.3)
Substance
Prox. u. URS 14 (100) 0 0 1
m-URS 14 (100) 0 0 2
Distal u. URS 14 (100) 0 0 3
m-URS 14 (100) 0 0 4
MUSCLE LAYER
Nucleus
Prox. u. URS 7 (50.0) 7 (50.0) 0 1 4 0.0 (−0.4; 0.4)
m-URS 12 (85.7) 2 (18.2) 0 2 10 0.2 (−0.1; 0.5)
Distal u. URS 8 (57.1) 4 (28.6) 2 (18.2) 3 5 0.0 (−0.4; 0.4)
m-URS 9 (64.3) 2 (18.2) 3 (21.4) 4 2 0.2 (−0.1; 0.5)
Cytoplasm
Prox. u. URS 14 (100) 0 0 1
m-URS 14 (100) 0 0 2
Distal u. URS 14 (100) 0 0 3
m-URS 14 (100) 0 0 4
SEROSA
Serosa
Prox. u. URS 10 (71.4) 2 (18.2) 2 (18.2) 1 7.5 0.0 (−0.3; 0.3)
m-URS 11 (78.6) 2 (18.2) 1 (7.1) 2 5 0.0 (−0.3; 0.3)
Distal u. URS 10 (71.4) 2 (18.2) 2 (18.2) 3 2.5 −0.1 (−0.4; 0.3)
m-URS 11 (78.6) 2 (18.2) 1 (7.1) 4 7.5 −0.1 (−0.4; 0.3)
Table 4. Immunohistochemical evaluation. Wil.+: Wilcoxon positive range statistic. C. Cliff ’s delta. 95% CI: 
95% confidence interval for Cliff ’s delta. L: Legend, comparison between 1; Distal u. URS vs Prox. u. URS, 2; 
Distal u. m-URS vs Prox. u. m-URS, 3; Distal u. URS vs Distal u. m-URS, 4; Distal u. URS - Prox. u. Baseline 
URS vs Distal u. m-URS – Prox. u. m-URS, *p < 0.05, **p < 0.01.
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First, a blood sample was drawn for hematological and biochemical analyses. Second, ultrasonographic (US) evalu-
ation of both kidneys was performed, and the Hydronephrosis Score (HS) was recorded according to the Society of 
Fetal Urology classification15. Following this, the mucosal alterations at the ureteral orifice were categorized accord-
ing to a validated UOScore16 (UO0 = normal ureteral orifice; UO1 = enlarged ureteral orifice with light surround-
ing inflammatory reaction; UO2 = enlarged ureteral orifice with moderate surrounding inflammatory reaction; 
UO3 = enlarged ureteral orifice with severe surrounding inflammatory and cystic reaction). The urinary tract eval-
uation finished with a compression cystography to rule out vesicoureteral reflux (VUR), as previously described16.
Once the baseline evaluation was completed, a tissue ischemia marker, pimonidazole diluted in 100 ml of 
saline solution, was then injected as a slow intravenous infusion. Pimonidazole (Hypoxyprobe kit, NPI Inc. USA) 
was administered at a dose of 0.3–0.5 g/m2 body surface area via the intravenous route.
Phase II: Ureteroscopy/micro-ureteroscopy. After Phase I of the study, we started Phase II, which consisted 
of the endoscopic exploration of both ureters in each pig. In 14 ureters (7 rights and 7 lefts ureters) the ureteros-
copy was carried out using a conventional 8/9.8 F ureteroscope (Richard Wolf Medical Instruments©, Knittlingen, 
Germany), forming the URS group. The other 14 ureters were explored with micro-ureteroscopy (m-URS group) with 
the MicroPerc® set (Polydiagnost, Hallbermoos, Germany). Specifications of both ureteroscopes are shown in Fig. 1.
In the m-URS group, access to the ureteral orifice was carried out without a safety guide, while in the URS 
group access to the ureteral orifice was carried out using a 0.035” hydrophilic safety guide. Following insertion 
of the ureteroscope, the distance from the tip of the endoscope to the external urethral meatus of the animal was 
kept fixed at 21 cm. In all cases, the first step was the evaluation of the ureteral orifice (UO Score), and the endo-
scopic appearance of the ureteral lumen was scored by the PULS13. Small movements were made in the craniocau-
dal direction, and a straight-tipped 230–270 µm laser fiber was used to simulate a therapeutic intervention. The 
irrigation system was always achieved with a gravity irrigation system, placing a normal saline bag 70 cm above 
the level of the animal, and the total irrigation saline volume was recorded.
The exploration time was determined according to scientific literature, so URS group was 60 min and m-URS 
was 45 min17. Once the exploration was completed, ureteral wall injury was scored by PULS and the ureteral 
orifice damage by the UO Score.
The experimental phase was carried out by two surgeons with extensive experience in both endourological 
techniques. The two study techniques, ureteroscopy and micro-ureteroscopy, were alternated in each animal. 
Accordingly, each surgeon performed 7 URS and 7 m-URS, representing a total of 28 procedures in 14 animals.
Figure 5. Ureter. (A) Positive pimonidazole immunohistochemical staining at the epithelial level (nucleus 
and cytoplasm), in cells of the lamina propria and nuclei of muscle cells. (B) Negative pimonidazole 
immunohistochemical staining. (C) Pimonidazole immunohistochemical staining at the epithelial level (positive 
nucleus and negative cytoplasm). (D) Positive pimonidazole immunohistochemical staining at the epithelial level 
(nucleus and cytoplasm), negative in the lamina propria. (E) Positive pimonidazole immunohistochemical staining 
at the epithelial level (nucleus and cytoplasm), negative in the lamina propria. See flat epithelium (dilated ureter).
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The m-URS system consisted of a sheath measuring 22.5 cm in length and with a caliber of 4.85 F. The caliber 
was uniform over the entire length. The sheath, in turn, was fitted to a 3-Luer-Lock. The irrigation solution 
entered through one of the lateral arms of the adaptor. Optics measuring 0.9 mm in diameter with 120° vision and 
a resolution of 10,000 pixels was inserted through the central channel. A Tuohy Borst adaptor (Cook Medical, 
Bloomington, USA) was fitted to the third channel for the insertion of a laser fiber. The ureteral wall was evalu-
ated at the start and end of the procedure.
Phase III: Ex-vivo experiments. The animals were euthanized after completing both explorations. The 
experimental study was completed by removing the urinary tract en bloc. Microscopic evaluation was carried 
out by a pathologist blinded to the group to which the samples belonged. An evaluation was made of the ureteral 
wall in contact with the ureteroscope or micro-ureteroscope. This segment is henceforth referred to as the distal 
ureter. A segment of ureter located above the study zone and 1 cm below the ureteropelvic junction was used as a 
control. This section, which was not manipulated during the exploration, is henceforth referred to as the proximal 
ureter. The minimum distance between the ureteropelvic junction and the explored zone was approximately 9 cm. 
A pathological classification was used with the hematoxylin-eosin–stained specimens to score 6 parameters from 
0–3 (where 0 = no changes and 3 = severe changes). Wall inflammation, fibrosis of the lamina propria, muscle 
fibrosis, integrity of the muscle layer and alterations of the serosal layer were studied. The immunohistochemical 
analysis, in turn, assessed the presence or absence of staining in each of the ureteral layers, considering the cell 
nucleus and cytoplasm separately. Staining was scored as absent, present in a few cells, or present in most cells.
Statistical analysis. The study was designed based on conservative criteria conditioned to ethics in animal 
experimentation. A total of 14 individuals was calculated as the sample size needed for a global frequency of 
complications associated with the procedure of 25%18, an expected reduction of complications to 1%, a statistical 
power of 75% and an alpha error of 0.1.
In the present study, all the outcome variables were ordinal; Cohen’s delta, therefore, was the best choice for 
contrasting the effect size between the two procedures. However, this effect measure is based on averages and 
variances and therefore constitutes a parametric-effect indicator. Our sample size was small, and Cohen’s delta 
was, therefore, not the best option. Cliff ’s delta (C) was best suited for our purposes. In all cases, Cliff ’s delta lies 
between 1 and −1, where 1 and −1 are interpreted as representing extreme effect sizes, while 0 is indicative of 
a null effect. Values of about ±0.11 represent a small effect, ±0.28 is indicative of a medium effect, and ±0.43 is 
indicative of a substantial effect. Positive values of Cliff ’s delta were indicative of increased damage when com-
paring the two procedures or comparing them with their controls. In contrast, negative values were indicative of 
lesser damage. Both Cliff ’s delta and the corresponding confidence interval were calculated using the R statistical 
application and its “effsize” package (version of November 2016).
Figure 6. Ureter. (A) Positive pimonidazole immunohistochemical staining of the almost entirely lost 
epithelium (nucleus and cytoplasm) and in some cells of the lamina propria. (B) Positive pimonidazole 
immunohistochemical staining at the epithelial level (nucleus and cytoplasm), in cells of the lamina propria 
and nuclei of muscle cells. (C) Positive pimonidazole immunohistochemical staining at the epithelial level 
(nucleus and cytoplasm of some cells) and in nuclei of muscle cells. (D) Amplification of image C. (E) Positive 
pimonidazole immunohistochemical staining of some epithelial cells, negative in the lamina propria. Note the 
difference between positive and negative cells. (F) Amplification of image (E) Positive and negative cells in the 
same sample. Positive nucleus and positive and negative cytoplasm.
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Likewise, a comparison of paired means would not be the best option for detecting associations between the 
procedures used and the damage caused. With a sample size of 14 individuals per group, we decided to substitute 
such comparison with the Wilcoxon signed rank test. Both the SPSS statistics Version 15 (IBM, Armonk, USA) 
and the R statistical application were used for the contrasting hypotheses.
Comparisons were made between the cases and controls within each procedure; the cases of one procedure 
versus the cases of the other; and finally, between the cases and controls of the two procedures. This approach 
allowed us to consider the damage caused from the starting point, which was not necessarily the same in all cases. 
In the absence of damage in the controls of both procedures, the latter two comparisons would be equivalent.
Data availability statement. All data are available upon request.
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